登录 注册 会员服务 联系我们

Research and development of mAb drugs in China: a look from policy perspectives

  • Published:2019-05-22 Issue:11 Volume:15 Page:2695-2705
  • ISSN:2164-5515
  • Container-title:Human Vaccines & Immunotherapeutics
  • language:en
  • Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Jiang Rong12,Sun Yuanyuan1,Ung Carolina3,Dong Xinyue1ORCID,Kong Xiangjun2,Hu Yuanjia3ORCID,Shao Rong12

Affiliation:

1. School of International Pharmaceutical Business, China Pharmaceutical University, Jiangsu, China

2. The Research Center of National Drug Policy & Ecosystem, Nanjing, China

3. State Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau, China

Funder

National Office for Philosophy and Social Sciences

University of Macau

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference27 articles.

1. Research and development of therapeutic mAbs: An analysis based on pipeline projects

2. CNII. Market data analysis of mAb drugs industry in China; 2017 Oct 20 [accessed 2019 Mar 6]. http://www.chyxx.com/industry/201710/574555.html.

3. Hui X. Domestic PD-1 drugs achieve zero breakthrough; 2018 Jun 19 [accessed 2019 Mar 6]. http://www.xinyaohui.com/news/201806/19/10319.html.

Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3